Ceres Nanosciences is a privately held company, located in Northern Virginia, focused on incorporating its proprietary Nanotrap® particle technology into a range of diagnostic and research use products and workflows. Nanotrap® particles capture, concentrate, and preserve low abundance analytes from biological samples, enabling early and accurate detection of diseases. The Nanotrap® particle technology was developed with support from the National Institutes of Health, the Defense Advanced Research Projects Agency, the Bill and Melinda Gates Foundation, Schmidt Futures, the Defense Threat Reduction Agency, the Centers for Disease Control and Prevention, and the Commonwealth of Virginia.
Ceres' mission is to deliver innovative products powered by the groundbreaking Nanotrap® technology to address life science needs and provide better patient outcomes.
Innovation >>
Collaboration >>
Quality >>
Create innovative solutions with our technology and talent.
Engage with our coworkers, partners, and customers to achieve our collective goals.
Deliver the highest caliber products and solutions.
Ceres is ISO 9001:2015 certified
Our commitment to quality means: Customers can have confidence that our products will meet their requirements; Partners and employees have a collaborative environment in which to pursue our mutual goals; We continually improve our processes and operations to better meet our goals and serve our customers.
Leadership Team
Ross Dunlap
Chief Executive Officer
Ben Lepene
Chief Technology Officer
Robbie Barbero, Ph.D.
Chief Business Officer
Tara Jones-Roe
VP of Sales and Marketing
Board and Advisors
Board of Directors
